Health · 1 sources covering this

STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO

A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO
A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/20034401cef4734ed40e6e06f5370d00708993a1"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO"></iframe>

STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO

How 1 sources are covering this

STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO

More from Health

STAT+: Rising premiums, a sad Medicaid gathering, and a new fraud crackdown

STAT+: Five biotech updates to read after ESMO this weekend

STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more

A virus that afflicts cows makes the jump to a human

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO

More from Health

STAT+: Rising premiums, a sad Medicaid gathering, and a new fraud crackdown

STAT+: Five biotech updates to read after ESMO this weekend

STAT+: Pharmalittle: We&#8217;re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more

A virus that afflicts cows makes the jump to a human

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more